Blue Path Capital Management, LLC Gilead Sciences, Inc. Transaction History
Blue Path Capital Management, LLC
- $240 Billion
- Q3 2025
A detailed history of Blue Path Capital Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Blue Path Capital Management, LLC holds 13,638 shares of GILD stock, worth $1.69 Million. This represents 0.63% of its overall portfolio holdings.
Number of Shares
13,638
Previous 10,656
27.98%
Holding current value
$1.69 Million
Previous $1.18 Billion
28.14%
% of portfolio
0.63%
Previous 0.57%
Shares
9 transactions
Others Institutions Holding GILD
# of Institutions
2,368Shares Held
1.01BCall Options Held
8.63MPut Options Held
7.39M-
Black Rock Inc. New York, NY121MShares$15 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.8 Billion0.21% of portfolio
-
State Street Corp Boston, MA59.1MShares$7.33 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA45.2MShares$5.61 Billion0.72% of portfolio
-
Dodge & Cox San Francisco, CA30.1MShares$3.74 Billion1.93% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $156B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...